# How CYP2D6 Polymorphism Modulates the Community-Wide Risk of Plasmodium vivax Infection: A Panel Study in Amazonian Brazil

**Authors:** Maria Carolina Silva de Barros Puça, Isabela Marques Naziazeno, Viviane Cristina Fernandes dos Santos, Priscila Thihara Rodrigues, Priscila Rodrigues Calil, Winni Alves Ladeia, José Pedro Gil, Marcelo Urbano Ferreira, Tais Nobrega De Sousa

PMC · DOI: 10.1093/infdis/jiaf412 · The Journal of Infectious Diseases · 2025-08-19

## TL;DR

This study explores how genetic differences in the CYP2D6 enzyme affect the spread and immunity to P. vivax malaria in a Brazilian community.

## Contribution

It reveals age-dependent shifts in infection patterns linked to CYP2D6 activity and its impact on malaria immunity.

## Key findings

- Children with impaired CYP2D6 activity had higher P. vivax infection rates compared to those with normal activity.
- Adolescents with normal CYP2D6 activity showed increased P. vivax prevalence over time.
- Adults with impaired CYP2D6 activity had lower parasite densities than younger individuals with normal activity.

## Abstract

The CYP2D6 enzyme plays a critical role in the metabolism of primaquine, the most widely used drug for the radical cure of Plasmodium vivax malaria. Impaired CYP2D6 activity has been associated with an increased risk of relapse. However, the overall impact of CYP2D6 on infection dynamics is still not fully understood. We hypothesized that individuals with impaired CYP2D6 activity develop partial immunity more rapidly due to the ineffective clearance of hypnozoites.

To test this hypothesis, we conducted a community-based study involving ∼1300 individuals genotyped for CYP2D6 and assessed repeatedly for P. vivax using molecular diagnosis. This approach allowed us to detect and monitor submicroscopic and asymptomatic infections over a 4-year follow-up period.

In our cohort, children with impaired CYP2D6 activity exhibited a higher frequency of P. vivax infections compared with those with normal enzyme activity. This pattern changed during the second decade of life, as the prevalence of P. vivax infection increased in adolescents with normal enzyme activity (P = .0008, Generalized additive mixed model). Consistent with this, parasite densities were lower in adults with impaired CYP2D6 activity compared with younger individuals with normal enzyme activity (P = .0383, Linear mixed model).

These findings underscore the potential role of CYP2D6 in shaping infection dynamics and malaria immunity in endemic areas.

This study investigated whether individual variation in primaquine metabolism influences susceptibility to P. vivax by affecting hypnozoite clearance and immunity acquisition, revealing higher infection rates in children with impaired CYP2D6 activity and age-dependent shifts in infection patterns and parasite densities.

## Linked entities

- **Genes:** CYP2D6 (cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)) [NCBI Gene 1565]
- **Chemicals:** primaquine (PubChem CID 4908)
- **Diseases:** malaria (MONDO:0005136)

## Full-text entities

- **Diseases:** Impaired CYP2D6 (MESH:C563835), P. vivax infection (MESH:D016780), malaria (MESH:D008288), infection (MESH:D007239)
- **Chemicals:** primaquine (MESH:D011319)
- **Species:** Plasmodium vivax (malaria parasite P. vivax, species) [taxon 5855]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12526952/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12526952/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12526952/full.md

---
Source: https://tomesphere.com/paper/PMC12526952